Sarah Granger-Glauser
Adult Health · Austin, TXNPI 1023388725
Payments from drug & device makers
Across 318 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$611
- Acadia Pharmaceuticals Inc$397
- Bristol Myers Squibb$344
- Boston Scientific$250
- Genentech USA, Inc.$237
- plus $2K from 28 others
Across 2 payments — averaging $175.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$350
What the payments were for
- Food & beverage$5,46798%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 101 | $1,601 |
| Novartis | 38 | $611 |
| Acadia Pharmaceuticals Inc | 21 | $397 |
| Bristol Myers Squibb | 26 | $344 |
| Boston Scientific | 8 | $250 |
| Genentech USA, Inc. | 14 | $237 |
| Abbott | 11 | $164 |
| Biohaven Pharmaceuticals, Inc. | 12 | $162 |
| Neurocrine Biosciences, Inc. | 9 | $157 |
| EMD Serono, Inc. | 8 | $153 |
| Biogen | 6 | $146 |
| Sanofi | 6 | $131 |
| Medtronic | 3 | $115 |
| Pfizer | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| Amgen | 4 | $106 |
| Amneal Pharmaceuticals LLC | 6 | $98 |
| Lilly USA, LLC | 4 | $79 |
| UCB, Inc. | 4 | $75 |
| SK Life Science, Inc. | 3 | $74 |
| Amylyx Pharmaceuticals, Inc. | 2 | $61 |
| MDD US Operations, LLC | 3 | $48 |
| Acorda Therapeutics, Inc | 2 | $47 |
| GE HealthCare | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 3 | $38 |
| Biodelivery Sciences International, Inc. | 2 | $29 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Adamas Pharmaceuticals, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$102
How this compares
$5,565 in reported general payments places this provider in the 90th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 24 | $25,725 |
| Nurtec OdtRimegepant Sulfate | 14 | $13,908 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 22 | $8,770 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 152 | $3,455 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 52 | $2,030 |
| AmantadineAmantadine Hcl | 15 | $1,176 |
| Rasagiline Mesylate | 20 | $1,048 |
| Gabapentin | 79 | $1,045 |
| Levetiracetam | 41 | $987 |
| Memantine Hcl | 41 | $983 |
| Donepezil Hcl | 92 | $885 |
| Duloxetine Hcl | 42 | $840 |
| Ropinirole ErRopinirole Hcl | 12 | $798 |
| Sertraline Hcl | 113 | $667 |
| Bupropion XlBupropion Hcl | 23 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCRytary | $98 | $25,72524 claims |
| PfizerNurtec Odt | $110 | $13,90814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 933 adult health providers in Texas.
Other adult health in Austin
- Elizabeth Wedberg SivamAustin$71K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Nicole BuschAustin$28K
- Marni MartinezAustin$14K
- Melani DayalAustin$13K
- Laura CalaisAustin$12K
- Shane ConcepcionAustin$10K
- Dorothy DarbyAustin$9K
- Lauren KissockAustin$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.